Skip to main content

About RSRT

Our singluar goal is to find cures for Rett syndrome as efficiently and quickly as possible. We will not rest until our children have them.

For us it’s personal. Our Chief Executive Officer and Chief Development Officer have a child with Rett. Twelve of our board members have a child, grandchild, or sibling with Rett. We are driven by the most profound motivator — love for our children and an unwavering commitment to change their lives and the lives of all with Rett.

Our scientific staff are equally dedicated. Their track record, integrity, and combined experience is unparalleled amongst Rett non-profits.


Our track record speaks for itself.


Roadmap to Cures 2.0

Built on decades of scientific advances Roadmap to Cures will select and drive three genetic medicines that attack the root cause of Rett syndrome to clinical trials by 2028.